The stock of Johnson & Johnson (JNJ) has seen a 0.50% increase in the past week, with a 2.47% gain in the past month, and a 11.76% flourish in the past quarter. The volatility ratio for the week is 1.08%, and the volatility levels for the past 30 days are at 1.56% for JNJ. The simple moving average for the last 20 days is -0.56% for JNJ stock, with a simple moving average of 5.01% for the last 200 days.
Is It Worth Investing in Johnson & Johnson (NYSE: JNJ) Right Now?
The price-to-earnings ratio for Johnson & Johnson (NYSE: JNJ) is above average at 28.22x, Company’s 36-month beta value is 0.49.Analysts have differing opinions on the stock, with 7 analysts rating it as a “buy,” 3 as “overweight,” 13 as “hold,” and 0 as “sell.”
The public float for JNJ is 2.41B, and currently, short sellers hold a 0.96% ratio of that floaft. The average trading volume of JNJ on March 24, 2025 was 8.80M shares.
JNJ) stock’s latest price update
The stock of Johnson & Johnson (NYSE: JNJ) has increased by 0.37 when compared to last closing price of 163.02. Despite this, the company has experienced a 0.50% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2025-03-22 that I have added Canadian Natural Resources and NextEra Energy to The Dividend Income Accelerator Portfolio, each representing 2.19% of our overall portfolio. These strategic acquisitions help us to further optimize the portfolio’s mix of dividend income and dividend growth. After these acquisitions, our dividend portfolio offers investors a Weighted Average Yield on Cost [TTM] of 4.43% and a 5-Year Weighted Average Dividend Growth Rate [CAGR] of 7.53%.
Analysts’ Opinion of JNJ
Many brokerage firms have already submitted their reports for JNJ stocks, with BofA Securities repeating the rating for JNJ by listing it as a “Neutral.” The predicted price for JNJ in the upcoming period, according to BofA Securities is $166 based on the research report published on December 10, 2024 of the previous year 2024.
Wolfe Research, on the other hand, stated in their research note that they expect to see JNJ reach a price target of $190. The rating they have provided for JNJ stocks is “Outperform” according to the report published on November 15th, 2024.
Daiwa Securities gave a rating of “Neutral” to JNJ, setting the target price at $150 in the report published on July 23rd of the previous year.
JNJ Trading at 4.47% from the 50-Day Moving Average
After a stumble in the market that brought JNJ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -3.74% of loss for the given period.
Volatility was left at 1.56%, however, over the last 30 days, the volatility rate increased by 1.08%, as shares surge +0.82% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +11.90% upper at present.
During the last 5 trading sessions, JNJ rose by +0.50%, which changed the moving average for the period of 200-days by +10.76% in comparison to the 20-day moving average, which settled at $164.55. In addition, Johnson & Johnson saw 13.14% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at JNJ starting from Decker Robert J, who sale 6,999 shares at the price of $165.88 back on Feb 25 ’25. After this action, Decker Robert J now owns 21,001 shares of Johnson & Johnson, valued at $1,160,994 using the latest closing price.
Decker Robert J, the Officer of Johnson & Johnson, proposed sale 6,999 shares at $165.88 during a trade that took place back on Feb 25 ’25, which means that Decker Robert J is holding shares at $1,161,010 based on the most recent closing price.
Stock Fundamentals for JNJ
Current profitability levels for the company are sitting at:
- 0.25 for the present operating margin
- 0.69 for the gross margin
The net margin for Johnson & Johnson stands at 0.16. The total capital return value is set at 0.17. Equity return is now at value 20.06, with 8.09 for asset returns.
Based on Johnson & Johnson (JNJ), the company’s capital structure generated 0.34 points at debt to capital in total, while cash flow to debt ratio is standing at 0.66. The debt to equity ratio resting at 0.51. The interest coverage ratio of the stock is 29.2.
Currently, EBITDA for the company is 24.78 billion with net debt to EBITDA at 0.51. When we switch over and look at the enterprise to sales, we see a ratio of 4.58. The receivables turnover for the company is 4.69for trailing twelve months and the total asset turnover is 0.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.11.
Conclusion
In a nutshell, Johnson & Johnson (JNJ) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
